Nephros Inc. (NEPH) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Nephros Inc. (NEPH:NASDAQ), powered by AI.

Current Price
$3.50
P/E Ratio
31.1
Market Cap
37M
Sector
Healthcare
What is the Nephros Inc. stock price forecast?

Nephros Inc. is currently trading at $3.50. View real-time AI analysis on Alpha Lenz.

What is Nephros Inc. insider trading activity?

View the latest insider trading data for Nephros Inc. on Alpha Lenz.

What is Nephros Inc.'s P/E ratio?

Nephros Inc.'s P/E ratio is 31.1.

Nephros Inc.

NASDAQ · NEPH
$3.50+0.26(+8.02%)Market closedNASDAQ regular session 09:30–16:00 ET
Ask about Nephros Inc.'s future dividend policy...
Alpha Chat Insight

Nephros Inc. trades at a P/E of 31.1 (premium valuation) with solid ROE of 12.7%. 3Y revenue CAGR of 23.5% highlights clear growth momentum.

Ask for details

Company Overview

Nephros Inc. is a company that specializes in the development and sale of filtration and ultrafiltration devices. Primarily focusing on providing high-quality, robust filtration solutions, Nephros serves medical institutions, commercial facilities, and the military sector. The company's product portfolio includes hemodiafilters and ultrafilters, which are integral in kidney dialysis and ensuring water is adequately purified for various healthcare and industrial applications. Nephros's technological advancements in filtration enhance safety and operational efficiency, impacting sectors like healthcare equipment manufacturing, water treatment, and hospitality services. By addressing the critical need for clean water and advanced dialysis treatments, Nephros plays a vital role in both enhancing public health standards and improving patient outcomes in medical settings.

CEOMr. Robert Banks
SectorHealthcare
IndustryMedical Instruments & Supplies
Employees31

Company Statistics

FY 2025

Profile

$37.14MMarket Cap
$18.79MRevenue
0.00Shares Out
31Employees

Margins

61.87%Gross
7.58%EBITDA
6.10%Operating
6.42%Pre-Tax
6.35%Net

Valuation

31.11P/E
3.64P/B
1.98EV/Sales
23.02EV/EBITDA
22.58P/FCF

Growth (CAGR)

23.50%Rev 3Yr
17.02%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

9.61%ROA
12.71%ROE
9.71%ROIC

Financial Health

$5.40MCash & Cash Equivalents
$-1.96MNet Debt
33.71%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Nephros Inc. (ticker: NEPH) is a company listed on NASDAQ in the Healthcare sector (Medical Instruments & Supplies). It has approximately 31 employees. Market cap is $37M.

The current price is $3.5 with a P/E ratio of 31.11x and P/B of 3.64x.

ROE is 12.71% and operating margin is 6.10%. Annual revenue is $19M.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Nephros Inc. (NEPH) Stock Forecast 2026 $3.50 — Price, Financials & Analyst Targets | Alpha Lenz